El-Rayes BF - Search Results

1

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancer.

Hussain M, Smith DC, El-Rayes BF, Du W, Vaishampayan U, Fontana J, Sakr W, Wood D. Hussain M, et al. Urology. 2003 Apr;61(4):774-80. doi: 10.1016/s0090-4295(02)02519-0. Urology. 2003. PMID: 12670564 Clinical Trial.

2

Hormonal therapy for prostate cancer: past, present and future.

el-Rayes BF, Hussain MH. el-Rayes BF, et al. Expert Rev Anticancer Ther. 2002 Feb;2(1):37-47. doi: 10.1586/14737140.2.1.37. Expert Rev Anticancer Ther. 2002. PMID: 12113064 Review.

3

A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.

El-Rayes BF, Zalupski MM, Shields AF, Ferris AM, Vaishampayan U, Heilbrun LK, Venkatramanamoorthy R, Adsay V, Philip PA. El-Rayes BF, et al. Invest New Drugs. 2005 Dec;23(6):583-90. doi: 10.1007/s10637-005-1028-z. Invest New Drugs. 2005. PMID: 16034525 Free article. Clinical Trial.

4

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.

Ben-Josef E, Shields AF, Vaishampayan U, Vaitkevicius V, El-Rayes BF, McDermott P, Burmeister J, Bossenberger T, Philip PA. Ben-Josef E, et al. Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):454-9. doi: 10.1016/j.ijrobp.2003.11.019. Int J Radiat Oncol Biol Phys. 2004. PMID: 15145162

5

Hormone-refractory prostate cancer responding to capecitabine.

El-Rayes BF, Black CA, Ensley JF. El-Rayes BF, et al. Urology. 2003 Feb;61(2):462. doi: 10.1016/s0090-4295(02)02248-3. Urology. 2003. PMID: 12597973

6

Cellular DNA content parameters as prognostic indicators in human astrocytomas.

El-Rayes BF, Norton CS, Sakr W, Maciorowski Z, Smith D, Pietraszkiewicz H, Del Mar Alonso M, Ensley JF. El-Rayes BF, et al. J Neurooncol. 2005 Jan;71(2):85-9. doi: 10.1007/s11060-004-6044-x. J Neurooncol. 2005. PMID: 15690121

7

A phase I study of flavopiridol and docetaxel.

El-Rayes BF, Gadgeel S, Parchment R, Lorusso P, Philip PA. El-Rayes BF, et al. Invest New Drugs. 2006 Jul;24(4):305-10. doi: 10.1007/s10637-005-4343-5. Invest New Drugs. 2006. PMID: 16683073 Clinical Trial.

8

A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin.

El-Rayes BF, Zalupski M, Shields AF, Manza SG, LoRusso P, Philip PA. El-Rayes BF, et al. Am J Clin Oncol. 2007 Apr;30(2):101-5. doi: 10.1097/01.coc.0000251223.98193.f4. Am J Clin Oncol. 2007. PMID: 17414457 Clinical Trial.

9

A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primary.

El-Rayes BF, Shields AF, Zalupski M, Heilbrun LK, Jain V, Terry D, Ferris AM, Philip PA. El-Rayes BF, et al. Am J Clin Oncol. 2005 Apr;28(2):152-6. doi: 10.1097/01.coc.0000142590.70472.e2. Am J Clin Oncol. 2005. PMID: 15803009 Clinical Trial.

10

Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors.

El-Rayes BF, Ibrahim D, Shields AF, LoRusso PM, Zalupski MM, Philip PA. El-Rayes BF, et al. Invest New Drugs. 2005 Jan;23(1):57-62. doi: 10.1023/B:DRUG.0000047106.20104.a7. Invest New Drugs. 2005. PMID: 15528981 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters